Oxehealth, a medtech spin-out of Oxford University, appoints chairman ahead of development push.
Allan Wood has been named chairman of Oxford spin-out Oxehealth, which is commercialising contactless vital signs monitoring technology.
Founded last year, Oxehealth is using technology developed at the university’s Institute of Biomedical Engineering, and has funding of up to £500k ($779k) from commercialisation firm the IP Group, subject to certain development milestones being met.
Wood, formerly of emergency care provider Harmoni, will be responsible for forming new partnerships with technology and healthcare organisations, as well as working with the investment community.
He said: “Oxehealth has the capability to transform our partners’ propositions, with the next generation of contactless patient monitoring being a great example. There are many well established providers of primary and secondary healthcare services and many suppliers of applications who would benefit from Oxehealth’s technology. At Harmoni we partnered with the largest GP co-op to achieve scale and impact. At Oxehealth we have the same desire to collaborate rather than compete.”
